Quantitative measures detect sensory and motor impairments in multiple sclerosis
Introduction
Multiple sclerosis (MS) is a complex and clinically heterogeneous disease of the central nervous system that often results in marked disability. The lesions that occur in MS can cause many neurological deficits, depending on their location and extent [1]. Common deficits include impairments of sensation, pyramidal tract dysfunction, and gait abnormalities. Evaluating MS disability has consistently relied on rating scales such as the Expanded Disability Status Scale (EDSS) [2], the Scripps Neurologic Rating Scale [3], the 12-item MS Walking Scale [4], and the Ambulation index [5]. These rating scales provide a good overall assessment of an individual's functional status; however, it is well-known that they are insensitive to subtle abnormalities and provide limited information about which impairments may be specifically contributing to an individual's loss of function [1], [6], [7]. Clinical rehabilitation studies could gain both statistical power and meaning from the use of more specific outcome measures that are sensitive to subtle neurological impairments [6], [7].
Quantitative functional testing devices such as the Vibratron II (for vibration sensation) and the hand-held dynamometer (for strength) have been used to evaluate impairments in sensation and strength for various neurological conditions including adrenomyeloneuropathy, cerebral palsy, traumatic brain injury, and peripheral neuropathy [8], [9], [10], [11], [12], [13], [14]. These devices are clinically accessible and have the potential for systematically quantifying specific impairments in MS; however, this has not been investigated. Using the same devices in a previous study, we found that impairments in vibration sensation and strength were significantly correlated with column-specific abnormalities in the spinal cord of MS subjects [15], [16]. What remains unclear is whether these tools can reliably differentiate MS impairments from controls, distinguish impairments between MS subtypes, and whether they are as sensitive or more sensitive than categorical rating scales in detecting impairments.
We hypothesized that the Vibratron II and the hand-held dynamometer are able to detect abnormalities of sensory and motor impairments in a heterogeneous group of MS patients and that they are more precise than their respective sensory and pyramidal functional system scores (FSS) of the EDSS (i.e., a global measures of disability in MS). The primary objectives of this study were to: 1) obtain baseline reference values for lower extremity quantitative sensorimotor measures in MS subjects, 2) examine whether these quantitative measures detect differences between MS subjects and matched controls, 3) compare these measures between MS subtypes, 4) evaluate the extent to which these measures correlate with global disability measures such as the EDSS and 5) evaluate their sensitivity compared to their respective EDSS FSS. This study provides the framework to begin validating the use and reliability of the Vibratron II and hand-held dynamometer as relevant MS clinical biomarkers of sensory and motor impairment.
Section snippets
Participants
Participants were recruited by convenience sampling from the Johns Hopkins MS Center from November 2004 to July 2009. Participants were excluded if they had an MS relapse within three months of testing or reported a history of peripheral neuropathy. All participants provided signed, informed consent in accordance with Institutional Review Board regulations at Johns Hopkins University and Kennedy Krieger Institute.
To address our study objectives we examined 145 individuals with MS using
Study population
In the cohort of 145 MS subjects, there was a mean age of 43.6 ± 11.9 years (mean ± SD) (range: 20–67), mean disease duration of 10.4 ± 9.6 years (range: 1–44), and 66% were females. Our MS subjects represented a wide range of disease disability (EDSS: 0–7.5) and their characteristics divided by disease subtype are presented in Table 1. Table 2A summarizes our MS cohort's vibration sensation with raw and normalized values. Table 2B summarizes our MS cohort's strength with raw and normalized values.
Discussion
Our data show that we can validly quantify lower extremity vibration sensation and strength in individuals with MS using clinically accessible tools and that these tools can detect differences among MS subtypes (i.e., RRMS, SPMS, and PPMS) and healthy controls. Vibration sensation and strength were significantly correlated to MS subtype and we found significant differences that were dependent on disease duration. Overall, all MS subtypes had significantly worse vibration sensation and strength
Funding
This work was supported by a Sylvia Lawry Physician Fellowship from the National Multiple Sclerosis Society (S.D.N.); NMSS Tissue Repair Grant (K.M.Z. and P.A.C.); NIH NICHD [grant number K01 HD049476] (K.M.Z.); and the Dana Foundation (K.M.Z.).
Acknowledgments
The authors would like to thank Divya Sambandan and Mike Shteyman for their assistance in collecting parts of this data and Dr. Joseph Arezzo for providing some of the Vibratron control data.
References (38)
- et al.
Test–retest reliability of hand-held dynamometric strength testing in young people with cerebral palsy
Arch Phys Med Rehabil
(2004) - et al.
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
Lancet
(2009) - et al.
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
Lancet Neurol
(2009) - et al.
The force/time relationship of clinically used sensory testing instruments
J Hand Ther
(1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years
Arch Phys Med Rehabil
(1997)- et al.
Effect of walking speed changes on tibialis anterior EMG during healthy gait for FES envelope design in drop foot correction
J Electromyogr Kinesiol
(2007) - et al.
The measurement of ambulatory impairment in multiple sclerosis
Neurology
(1997) Rating neurologic impairments in multiple sclerosis: an Expanded Disability Status Scale (EDSS)
Neurology
(1983)- et al.
A neurologic rating scale (NRS) for use in multiple sclerosis
Neurology
(1984) - et al.
Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)
Neurology
(2003)
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH
NEJM
Are quantitative functional measures more sensitive to worsening MS than traditional measures?
Neurology
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
Brain
Sensorimotor function and axonal integrity in adrenomyeloneuropathy
Arch Neurol
Hand-held dynamometry in children with traumatic brain injury: within-session reliability
Pediatr Phys Ther
Prevalence of peripheral neuropathy in injection drug users
Neurology
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology
Quantitative measurements of vibration threshold in healthy adults and acrylamide workers
Int Arch Occup Environ Health
Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy
Neurology
Cited by (55)
Factors contributing to falls in people with multiple sclerosis: The exploration of the moderation and mediation effects
2023, Multiple Sclerosis and Related DisordersEstablishment of regression-based normative isometric strength values for major lower limb muscle groups in persons with multiple sclerosis
2023, Multiple Sclerosis and Related DisordersSpatiotemporal gait changes in people with multiple sclerosis with different disease progression subtypes
2022, Clinical BiomechanicsCognition and proprioception in persons with multiple sclerosis and healthy controls: Nascent findings
2022, Multiple Sclerosis and Related DisordersCitation Excerpt :Proprioception is challenging to measure in the clinic environment, as there is no standardized quantitative measure. However, both proprioception and vibratory sensation are carried along the dorsal columns; thus, our lab has established quantitative vibratory sensation as a reliable and valid proxy measure of proprioception in persons with MS (Newsome et al., 2011; Fritz et al., 2019). Vibratory sensation reflects pathological differences in spatially distinct areas of the central nervous system and supplements information obtained with brain imaging measures of atrophy, particularly in persons with progressive MS (Fritz et al., 2019).
Cerebellar Contributions to Motor and Cognitive Control in Multiple Sclerosis<sup>✰✰✰</sup>
2022, Archives of Physical Medicine and Rehabilitation